Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Nature Medicine|April 16, 2013
A colorectal cancer classification system that associates cellular phenotype and responses to therapyAnguraj Sadanandam, Costas A Lyssiotis, Krisztian Homicsko, et al.
Trials|August 31, 2017
A rectal cancer feasibility study with an embedded phase III trial design assessing magnetic resonance tumour regression grade (mrTRG) as a novel biomarker to stratify management by good and poor response to chemoradiotherapy (TRIGGER): study protocol for a randomised controlled trialNick J Battersby, Mit Dattani, Sheela Rao, et al.
Scientific Reports|May 23, 2019
Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular SubtypesChanthirika Ragulan, Katherine Eason, Elisa Fontana, et al.
Biorxiv : the Preprint Server for Biology|April 17, 2023
Inhibition of serotonin biosynthesis in neuroendocrine neoplasm suppresses tumor growth in vivoDane H Tow, Catherine G Tran, Luis C Borbon, et al.
BMC Medicine|December 17, 2009
A systems analysis of the chemosensitivity of breast cancer cells to the polyamine analogue PG-11047Wen-Lin Kuo, Debopriya Das, Safiyyah Ziyad, et al.
Nature|September 24, 2025
SPP1 is required for maintaining mesenchymal cell fate in pancreatic cancerHuafu Li, Linxiang Lan, Hengxing Chen, et al.
Journal for Immunotherapy of Cancer|March 8, 2021
Differential and longitudinal immune gene patterns associated with reprogrammed microenvironment and viral mimicry in response to neoadjuvant radiotherapy in rectal cancerAnna Wilkins, Elisa Fontana, Gift Nyamundanda, et al.
Gut|September 5, 2020
Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumoursKate Young, Rita T Lawlor, Chanthirika Ragulan, et al.
ESMO Open|September 24, 2020
Detection of postoperative plasma circulating tumour DNA and lack of CDX2 expression as markers of recurrence in patients with localised colon cancerNoelia Tarazona, Francisco Gimeno-Valiente, Valentina Gambardella, et al.
ESMO Open|April 10, 2019
Benefit from anti-EGFRs in RAS and BRAF wild-type metastatic transverse colon cancer: a clinical and molecular proof of concept studyChiara Cremolini, Matteo Benelli, Elisa Fontana, et al.
Pageof 7